Page results
-
Information about percutaneous endoscopic interlaminar lumbar discectomy for patients with sciatica.
-
Endoscopic spinal surgery (ESS) is a type of minimally invasive spinal surgery (keyhole surgery). This page provides information about transforaminal endoscopic lumbar discectomy (PTELD).
-
Information on the different ways you can travel to University College London Hospitals (UCLH) if you don’t qualify for patient transport. It also includes advice on financial support that may be available to you.
-
This page answers common questions about Acute Pancreatitis and how it is managed in North Central London (NCL).
-
This page is aimed at providing guidance and recommendations for patients, carers or family members following a high dose examination or procedure performed in the Neuroradiology department at NHNN, which involved ionising radiation.
-
This page provides information on transperineal biopsies of the prostate.
-
If your doctor has referred you for a blood test, please book your phlebotomy (blood test) appointment online in advance.
-
An evaluation of temporary changes to children and young people’s services in North Central London (NCL) in the autumn and winter of 2020/21 has been published.
-
Information about the Integrated General Medicine Service at the RLHIM patient information leaflet.
-
After delivering more than 80,000 vaccines, the vaccination centre at The Francis Crick Institute closes its doors today (13 August 2021) with the last vaccination taking place at 7pm.
File results
-
FOI/2023/0500 - Treatment of urothelial and colorectal cancer
-
FOI/2023/0501 - Central Airway Tumour Management/ Endobronchial Valves for treatment of Emphysema
-
FOI/2023/0505 - Telecommunications infrastructure contract
-
FOI/2023/0507 - Mental health patient suicides
-
FOI/2023/0508 - Lynch syndrome clinical pathway
-
FOI/2023/0509 - Immunoglobulin treatments
-
FOI/2023/0514 - Processes and software applications used in Urology
-
FOI/2023/0516 - Maternity management system
-
FOI/2023/0522 - Urology cancer pathway
-
FOI/2023/0523 - Treatment on Nivolumab